Skip to Main Content

David Fiellin, MD

Professor of Medicine (General Medicine), of Emergency Medicine, and of Public Health; Course Co-Director, Principles of Clinical Research, Investigative Medicine Program; Course Co-Director, Seminars in Clinical Investigation, Investigative Medicine Program; Director, Program in Addiction Medicine

Contact Information

David Fiellin, MD

Office Location

Mailing Address

  • Internal Medicine

    PO Box 208056, 333 Cedar Street

    New Haven, CT, 06520-8056

    United States

Research Summary

Dr. Fiellin has focused his scholarly work on the interface between primary care and substance abuse. He conducts research on the transfer of treatment strategies, including opioid agonist treatment with buprenorphine and alcohol pharmacotherapies, from specialized settings to office-based, primary care, emergency department and HIV specialty settings.

Specialized Terms: Substance abuse treatment in primary care; Emergency department and HIV specialty settings opioid agonist treatment with buprenorphine; Pharmacologic treatment of alcohol

Coauthors

Research Interests

Alcoholism; Buprenorphine; Health Policy; HIV; Internal Medicine; Opioid-Related Disorders; Public Health; Substance Withdrawal Syndrome; Tobacco Use Disorder; Substance Abuse Detection; Substance Abuse Treatment Centers; Clinical Trial; Multicenter Study; Meta-Analysis; Health Care Quality, Access, and Evaluation; Cocaine-Related Disorders; Alcohol-Related Disorders; Drug Overdose; Observational Study; Addiction Medicine; Marijuana Use; Implementation Science; Systematic Review

Selected Publications

Clinical Trials